Target intelligence / Profile preview

Mitochondrial genome maintenance exonuclease 1 (MGME1)

Target
MGME1
Molecular classification
Enzyme, Exonuclease, PD-(D/E)XK family nuclease
01

Overview

Mitochondrial genome maintenance exonuclease 1 (MGME1) is a metal-dependent, PD-(D/E)XK family single-stranded DNA exonuclease that localizes to mitochondria, where it is essential for the maintenance and replication of mitochondrial DNA (mtDNA)[1][3][8]. MGME1 preferentially cleaves single-stranded DNA flaps, performing both exonucleolytic (from a free 5′ or 3′ end) and endonucleolytic cleavage, but does not act on RNA[2][4][8]. Its activity is critical in processing primer/repair intermediates that arise during mtDNA replication, enabling the ligation of newly synthesized DNA strands and regulating the level of replication intermediates such as 7S DNA[1][2][7][8]. Loss-of-function mutations result in decreased mtDNA copy number, rearrangements, and accumulation of 7S DNA, causing multisystemic mitochondrial diseases in humans and tissue-dependent mtDNA defects in model organisms[1][3][7]. MGME1's function is tightly regulated and functionally associates with the DNA replicase Polγ[2][4]. Relevant details have been standardized per conventions provided, with disease and safety implications noted from functional and genetic studies. No approved drugs target MGME1 directly, and no drug mechanisms of action could be found in this context.

Other names
MGME1C20orf72DDK1MTDPS11bA504H3.4
02

Biological functions

Mitochondrial DNA replicationDNA repair (specifically removal of single-stranded DNA flaps during mtDNA replication)Maintenance of mitochondrial genome integrityProcessing of 7S DNA, a replication intermediate
03

Disease associations

Mitochondrial disease (multisystemic, due to loss-of-function mutations resulting in mtDNA depletion, deletions, duplications, and replication errors)Tissue-specific mitochondrial dysfunctionImplied indirect links to progeria in context of mitochondrial mutator mouse models, but MGME1 deficiency alone does not cause progeria
04

Safety considerations

Excess MGME1 leads to nonspecific ssDNA degradation and severe mtDNA depletionPathogenic loss-of-function mutations cause severe mitochondrial DNA maintenance disorders
05

Biomarkers

Accumulation of mitochondrial 7S DNA (indicative of MGME1 dysfunction)mtDNA depletion and deletions detectable in patient tissue/cells

Beyond the preview

Go deeper on Mitochondrial genome maintenance exonuclease 1 (MGME1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial genome maintenance exonuclease 1 (MGME1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call